West Pharmaceutical Services, Inc. (NYSE: WST) reported first-quarter 2024 adjusted earnings per share (ETF:EPS) of $1.56, which beat the Zacks Consensus Estimate by 20.9%. The bottom line, however, was down 21.2% year over year.
West Pharmaceutical Services (NYSE:WST – Get Free Report) and Gerresheimer (OTCMKTS:GRRMF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability. Institutional & Insider Ownership 91.2% of West Pharmaceutical […]
Financial Analysis: Venus Concept (NASDAQ:VERO) vs West Pharmaceutical Services (NYSE:WST) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
West Pharmaceutical Services (NYSE:WST – Get Free Report) and Apyx Medical (NASDAQ:APYX – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, valuation, profitability and analyst recommendations. Profitability This table compares West Pharmaceutical Services […]